801 related articles for article (PubMed ID: 20448470)
21. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.
Valentini D; Ferrara G; Advani R; Hallander HO; Maeurer MJ
BMC Immunol; 2015 Jul; 16():40. PubMed ID: 26129684
[TBL] [Abstract][Full Text] [Related]
22. Nonhuman primate and human challenge models of pertussis.
Merkel TJ; Halperin SA
J Infect Dis; 2014 Apr; 209 Suppl 1(Suppl 1):S20-3. PubMed ID: 24626867
[TBL] [Abstract][Full Text] [Related]
23. Roads to the development of improved pertussis vaccines paved by immunology.
Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH
Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400
[TBL] [Abstract][Full Text] [Related]
24. Pertussis control: time for something new?
Clark TA; Messonnier NE; Hadler SC
Trends Microbiol; 2012 May; 20(5):211-3. PubMed ID: 22494804
[TBL] [Abstract][Full Text] [Related]
25. Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity.
Allen AC; Mills KH
Expert Rev Vaccines; 2014 Oct; 13(10):1253-64. PubMed ID: 25017925
[TBL] [Abstract][Full Text] [Related]
26. Construction and preliminary immunobiological characterization of a novel, non-reverting, intranasal live attenuated whooping cough vaccine candidate.
Cornford-Nairns R; Daggard G; Mukkur T
J Microbiol Biotechnol; 2012 Jun; 22(6):856-65. PubMed ID: 22573165
[TBL] [Abstract][Full Text] [Related]
27. Pertussis: Where did we go wrong and what can we do about it?
Locht C
J Infect; 2016 Jul; 72 Suppl():S34-40. PubMed ID: 27161992
[TBL] [Abstract][Full Text] [Related]
28. Emerging Bordetella pertussis Strains Induce Enhanced Signaling of Human Pattern Recognition Receptors TLR2, NOD2 and Secretion of IL-10 by Dendritic Cells.
Hovingh ES; van Gent M; Hamstra HJ; Demkes M; Mooi FR; Pinelli E
PLoS One; 2017; 12(1):e0170027. PubMed ID: 28076445
[TBL] [Abstract][Full Text] [Related]
29. Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence.
Sealey KL; Belcher T; Preston A
Infect Genet Evol; 2016 Jun; 40():136-143. PubMed ID: 26932577
[TBL] [Abstract][Full Text] [Related]
30. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against
Zurita ME; Wilk MM; Carriquiriborde F; Bartel E; Moreno G; Misiak A; Mills KHG; Hozbor D
Front Cell Infect Microbiol; 2019; 9():125. PubMed ID: 31106160
[TBL] [Abstract][Full Text] [Related]
31. Human Immune Responses to Pertussis Vaccines.
Ausiello CM; Mascart F; Corbière V; Fedele G
Adv Exp Med Biol; 2019; 1183():99-113. PubMed ID: 31342460
[TBL] [Abstract][Full Text] [Related]
32. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?
Mooi FR; van Loo IH; King AJ
Emerg Infect Dis; 2001; 7(3 Suppl):526-8. PubMed ID: 11485646
[TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations.
Farizo KM; Burns DL; Finn TM; Gruber MF; Pratt RD
J Infect Dis; 2014 Apr; 209 Suppl 1():S28-31. PubMed ID: 24626869
[TBL] [Abstract][Full Text] [Related]
34. Pertussis: persistent pathogen, imperfect vaccines.
Yeh SH
Expert Rev Vaccines; 2003 Feb; 2(1):113-27. PubMed ID: 12901603
[TBL] [Abstract][Full Text] [Related]
35. Pertussis vaccines: state-of-the-art and future trends.
Tefon BE; Özcengiz E; Özcengiz G
Curr Top Med Chem; 2013; 13(20):2581-96. PubMed ID: 24066885
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.
Boehm DT; Hall JM; Wong TY; DiVenere AM; Sen-Kilic E; Bevere JR; Bradford SD; Blackwood CB; Elkins CM; DeRoos KA; Gray MC; Cooper CG; Varney ME; Maynard JA; Hewlett EL; Barbier M; Damron FH
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30012638
[No Abstract] [Full Text] [Related]
37. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
Mills KH; Gerdts V
J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
[TBL] [Abstract][Full Text] [Related]
38. Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies.
Campbell PT; McCaw JM; McIntyre P; McVernon J
Vaccine; 2015 Oct; 33(43):5794-5800. PubMed ID: 26392008
[TBL] [Abstract][Full Text] [Related]
39. The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development.
Preston A
Hum Vaccin Immunother; 2016 May; 12(5):1274-6. PubMed ID: 26889694
[TBL] [Abstract][Full Text] [Related]
40. Investigating pertussis toxin and its impact on vaccination.
Coutte L; Locht C
Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
